Oregon Cannabis Tax Act 2012 News Conference


 

Oregon Cannabis Tax Act 2012 News Conference – Organizers of a new Oregon state initiative campaign, Oregon Cannabis Tax Act 2012 (OCTA2012), announce the kickoff of their petition drive and opening of their new office. The Oregon Secretary of State’s Election Division just announced the approval of the petition, Initiative Number 9, for circulation and signature gathering on March 24th. Organizers have until July 7, 2012 to gather 90000 registered Oregon voters’ signatures to qualify for the November 6, 2012 ballot. Organizers rallied petitioners at their new office on Monday, March 28th and held a news conference. The state campaign committee is working to achieve ballot status in three ways: hiring paid petitioners, organizing volunteer petitioners and soliciting Oregon registered voters signatures online. The Oregon Cannabis Tax Act of 2012 will regulate the legal sale of marijuana to adults through state-licensed stores, allow adults to grow their own, license Oregon farmers to grow marijuana for state-licensed stores and allow unlicensed Oregon farmers to grow cannabis hemp for fuel, fiber and food. OCTA2012 will raise 0 million a year by taxing commercial cannabis sales to adults 21 years of age and older, and save an estimated .5 million as law enforcement, corrections and judicial attention can focus on violent crimes and theft. We estimate this will amount to 0 million a year more funding for state government. Ninety percent of the proceeds will go into the state general fund, 7% for drug treatment

 

Ono's Experimental MS Drug Cuts Brain Lesions, Study Shows

Filed under: drug treatment news 2012

By Kanoko Matsuyama on April 16, 2012 An experimental drug to treat multiple sclerosis developed by Ono Pharmaceutical Co. (4528) reduced the number of lesions in the brain, a study to be presented at the American Academy of Neurology showed.
Read more on BusinessWeek

 

FDA schedules meeting with Cellceutix on psoriasis drug

Filed under: drug treatment news 2012

The FDA has confirmed mid-June 2012 for a meeting, the company said in a press release. In a statement, Cellceutix chief executive Leo Ehrlich said, ''The market potential for an effective psoriasis treatment that outperforms today's therapies is …
Read more on Boston.com

 

From Twitter:

RT @everyaddiction: NJ Gov. Christie calls for mandatory treatment for non-violent drug offenders – http://t.co/wiN4Chsc – by drugsreport (Drugs Report)

 

From Twitter:

MONDAY, April 16 (HealthDay News) — Teens undergoing treatment for alcohol or drug abuse can benefit from the 1… http://t.co/egvrwqxO – by prestyfrez (Frez)

 

From Twitter:

MONDAY, April 16 (HealthDay News) — Teens undergoing treatment for alcohol or drug abuse can benefit from the 1… http://t.co/eSmqupWG – by ama_20 (Ama)